NCT00311441.

Trial name or title	"A Phase IV, Randomized, Controlled, Single‐Blind, Multi‐Center Study in Children to Evaluate the Safety, Tolerability and Immunogenicity of Two TBE Vaccines Administered According to Two Different Schedules"
Methods	Randomized controlled trial; Phase IV study
Participants	Inclusion criteria: healthy male and female children; 1 to 10 years of age Exclusion criteria: documented tick‐borne encephalitis (TBE) infection and/or have been previously vaccinated with TBE vaccine
Interventions	2 TBE vaccines administered according 2 different schedules.
Outcomes	1. Immunogenicity measured by neutralization test and enzyme‐linked immunosorbent assay (ELISA) on days 28, 42, 300, and 321 2. Tolerability with respect to local and systemic reactions including fever
Starting date	March 2005
Contact information	Not provided
Notes	Location: Germany Sponsor: Novartis